68Ga-PNT-6555

N/A

Report date: 2025/12/26 09:51:49

Base Information

Drug Name68Ga-PNT-6555
Drug Alias NamePNT-6555-[68Ga]Gallium-68-PNT-6555
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsEsophageal Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPoint Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPoint Biopharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsEsophageal Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A